Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Roche Holding AG    ROG   CH0012032048

ROCHE HOLDING AG

(ROG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Most relevant news about ROCHE HOLDING AG
06:00aROCHE : DZ Bank Lifts Price Target on Roche, Maintains Hold Recommendation
MT
05:59aROCHE HOLDINGS AG : Credit Suisse sticks Neutral
MD
05:51aROCHE : Liberum Lifts Price Target on Roche, Maintains Hold Recommendation
MT
02:26aROCHE HOLDINGS AG : Jefferies maintains a Buy rating
MD
01/19CHUGAI PHARMACEUTICAL : Supports the Japan Climate Initiative's Calling to Raise..
AQ
01/18ROCHE ANNUAL GENERAL MEETING 2021 : Exercising of shareholder rights via the ind..
AQ
01/18PRESS RELEASE : Roche Annual General Meeting 2021: Exercising of shareholder rig..
DJ
01/15ROCHE HOLDINGS AG : Deutsche Bank gives a Neutral rating
MD
01/14Qiagen warns against using standard tests to track coronavirus variants
RE
01/13CHUGAI PHARMACEUTICAL : Conducts Digital Transformation in Manufacturing with IB..
AQ
01/13ROCHE : Exane BNP Paribas Lowers Price Target on Roche, Maintains Outperform Rec..
MT
01/13ROCHE HOLDINGS AG : JP Morgan reiterates its Neutral rating
MD
01/12ROCHE : Unit Regeneron to Supply Additional Doses of COVID-19 Antibody Cocktail ..
MT
01/12ROCHE : confirms US government agreement to purchase additional doses of Regener..
AQ
01/12PRESS RELEASE : Roche confirms US government -2-
DJ
01/12PRESS RELEASE : Roche confirms US government agreement to purchase additional do..
DJ
01/12ROCHE : CHEPLAPHARM acquires the rights to Rivotril
AQ
01/12ROCHE HOLDINGS AG : Receives a Buy rating from UBS
MD
01/12ROCHE : Tecentriq-Avastin Treatment Improves Survival Rate in Liver Cancer Patie..
MT
01/12ROCHE : to present updated data confirming Tecentriq in combination with Avastin..
AQ
01/12PRESS RELEASE : Roche to present updated data -2-
DJ
01/12PRESS RELEASE : Roche to present updated data confirming Tecentriq in combinatio..
DJ
01/11REGENERON PHARMACEUTICALS : says antibodies likely potent vs virus variants, Lil..
RE
01/11GLOBAL MARKETS LIVE: Tech giants and freedom of expression
01/11ROCHE : Trial of COVID-19 blood plasma finds no benefit in severely ill patients
RE
01/11Regeneron says COVID-19 antibody therapy will likely help against variants
RE
01/11ROCHE : Trial of COVID-19 blood plasma finds no benefit in severely ill patients
RE
01/11ROCHE : Xofluza approved by the European Commission for the treatment of influen..
AQ
01/11Soaring virus cases knock European stocks off 10-month high
RE
01/11ROCHE : Correction to Roche Influenza Treatment Article
DJ
01/11ROCHE : Influenza Treatment Approved by European Commission
DJ
01/11ROCHE : Debuts Two Automated Digital Pathology Image Analysis Algorithms for Bre..
MT
01/11ROCHE : Gets EU Approval for Influenza Treatment Xofluza
MT
01/11ROCHE : gets EU green light for influenza treatment Xofluza
RE
01/11ROCHE : launches two digital pathology image analysis algorithms for precision p..
AQ
01/11PRESS RELEASE : Roche launches two digital pathology image analysis algorithms f..
DJ
01/11ROCHE : Xofluza approved by the European Commission for the treatment of influen..
AQ
01/11PRESS RELEASE : Roche's Xofluza approved by the -2-
DJ
01/11PRESS RELEASE : Roche's Xofluza approved by the European Commission for the trea..
DJ
01/08COVID SCIENCE-Pfizer/BioNTech vaccine works against virus variants in lab; ar..
RE
01/08Coronavirus variants may lead to false negative results with molecular tests ..
RE
01/08ROCHE HOLDINGS AG : Morgan Stanley is less optimistic
MD
01/08ROCHE : Morgan Stanley Maintains Price Target on Roche, Downgrades Recommendatio..
MT
01/08ROCHE HOLDINGS AG : Berenberg gives a Neutral rating
MD
01/07ROCHE : Sanofi Arthritis Drugs Lower Fatality Rates in Severe COVID-19 Patients
MT
01/07Roche, Sanofi arthritis drugs reduce death rates among sickest COVID-19 patie..
RE
01/07ROCHE HOLDINGS AG : Credit Suisse sticks Neutral
MD
01/05ROCHE : Genentech Gets FDA Breakthrough Designation for Tiragolumab Combo
DJ
01/05ROCHE : Invitation to Roche's Full Year Results 2020 Presentation
PU
01/05ROCHE : Tiragolumab-Tecentriq Treatment for Lung Cancer Gets US FDA Breakthrough..
MT
01/05GENENTECH : 's Novel Anti-TIGIT Tiragolumab Granted FDA Breakthrough Therapy Des..
BU
01/05ROCHE : novel anti-TIGIT tiragolumab granted FDA Breakthrough Therapy Designatio..
AQ
01/05PRESS RELEASE : Roche's novel anti-TIGIT -2-
DJ
01/05PRESS RELEASE : Roche's novel anti-TIGIT tiragolumab granted FDA Breakthrough Th..
DJ
01/04ROCHE HOLDINGS AG : Gets a Buy rating from Bernstein
MD
01/04ROCHE HOLDINGS AG : JP Morgan gives a Neutral rating
MD
2020Chugai Obtains Approval for Expanded Use of FoundationOne CDx Cancer Genomic ..
AQ
2020HALOZYME THERAPEUTICS : Announces Roche Receives European Commission Approval fo..
AQ
2020ROCHE : Says New COVID-19 Strains Will Not Impact Tests
MT
2020Britain, Swiss firm Roche say COVID-19 tests can detect mutant virus
RE
2020CHUGAI PHARMACEUTICAL THE : Launch of Chugai's New TV Commercial Featuring Erika..
AQ
2020GLOBAL MARKETS LIVE : Airbus, Walmart, Roche…
2020ROCHE : Phesgo Breast Cancer Treatment Approved by European Commission
MT
2020ROCHE : European Commission approves Roche's Phesgo (fixed-dose combination of P..
AQ
2020PRESS RELEASE : European Commission approves -2-
DJ
2020PRESS RELEASE : European Commission approves Roche's Phesgo (fixed-dose combinat..
DJ
2020ROCHE : Bank Vontobel Lifts Price Target on Roche, Maintains Buy Recommendation
MT
2020GLOBAL MARKETS LIVE: Tesla, Apple, Lockheed Martin…
2020CHUGAI PHARMACEUTICAL : Osteoporosis Agent Edirol Obtains Regulatory Approval in..
AQ
2020ROCHE HOLDINGS AG : Buy rating from JP Morgan
MD
2020ASTRAZENECA : Tagrisso gets broader U.S. FDA nod for lung cancer
RE
2020ROCHE : Faricimab Meets Primary Endpoint in Two Phase 3 Studies
DJ
2020ROCHE : Eye Drug Faricimab Shows Durability in Late-Stage Clinical Studies
MT
2020ROCHE : EU Signs $122 Million Deal for COVID-19 Rapid Antigen Tests From Abbott,..
MT
2020ROCHE : faricimab meets primary endpoint and shows strong durability across two ..
AQ
1  2  3  4  5  6  7  8  9  10Next